Inhibikase Halts Parkinson's Drug Development to Focus on PAH
Inhibikase Therapeutics, Inc. (IKT), a biopharmaceutical company with a market capitalization of $189.48 million, has announced the halting of further development of its Parkinson's disease drug, ...
News Medical on MSN18h
AI model identifies potential risk genes for Parkinson's disease
Researchers from the Cleveland Clinic Genome Center have successfully applied advanced artificial intelligence (AI) genetics ...
Can mold exposure cause Parkinson's disease? Colorado family hopes to prove 'landmark' legal case
A Colorado Springs family hopes to win what they believe would be a landmark legal verdict by proving to jurors next month ...
TMJ414h
How boxing helps those with Parkinson's fight back against the disease in West Bend
WEST BEND, Wis. — Rock Steady Boxing participants live with a form of Parkinson's disease and want to raise awareness and ...
Northern Virginia Daily15h
Exercise class helps Parkinson's patients manage their symptoms
Patients living with Parkinson’s disease are encouraged to engage in regular exercise to help manage symptoms and improve ...
Boing Boing on MSN21h
New brain implant lets Parkinson's patient forget symptoms
A brain implant has allowed a Parkinson's patient to "forget about" his debilitating condition for days at a time. Kevin Hill ...